Megan covers the intersection of science and society. How is biomedical research funded? Who benefits? And how do new technologies reflect and shape our values? You can reach Megan on Signal at ...

The Department of Health's adoption of affordable generic Risdiplam for Spinal Muscular Atrophy marks a major victory for ...

Spinal muscular atrophy (SMA) is a genetic neuromuscular disease affecting specialized nerve cells that control voluntary muscle movement, according to the Muscular Dystrophy Association (MDA). It can ...

SCHAUMBURG, Ill., Aug. 7, 2026 /PRNewswire/ -- As August marks SMA Awareness Month, Cure SMA is drawing attention to its 2025 State of SMA report, an annual data resource that tracks the changing ...

Infantile spinal muscular atrophy (SMA) is a neuromuscular disorder that affects the nerve cells in the spinal cord. It causes muscles to weaken and limits muscle movement. SMA is a rare condition.

A comprehensive review details how three FDA-approved therapies have dramatically improved spinal muscular atrophy outcomes ...

Kerala health minister K Muraleedharan defended providing low-cost Indian SMA medicines, citing expert approval, while ...

Early diagnosis and treatment of SMA can limit disease progression in children and adults, extending life expectancy and improving QOL. Spinal muscular atrophy (SMA) is a severe genetic condition that ...

An international study has discovered that people living with the neurodegenerative condition spinal muscular atrophy (SMA) are at higher risk of developing fatty liver disease, suggesting that SMA ...

"Managing pain in patients with SMA begins with the recognition that there are predictable etiologies leading to pain in SMA and investigating them during each medical visit is important to implement ...

Spinal muscular atrophy (SMA) is a genetic, progressive neuromuscular disorder. SMA affects muscle-controlling nerve cells, called motor neurons, in the spinal cord. The condition leads to muscle ...